Free Trial

More results...

Filter by Content types
Regulatory databases
Regulatory reports
Market reports
News analysis
Filter by Geography
Africa
Asia
Australasia
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • Moldova Contradiction in regulations could delay hemp cultivation ...
  • Germany Large-scale cannabis cultivation facility plans halted ...
  • Portugal Polytechnic launches medical cannabis course ...
  • Arizona - United States Bill to limit number of medical cannabis dispensaries goes to governor ...
  • New Mexico - United States Bill to allow medical use of psilocybin heads to governor ...
  • Luxembourg Study shows almost a sixth of cannabis users started after law passed ...
  • Germany NGOs want changes to cannabis law to protect consumers from addiction ...
  • Canada Health Canada updates cannabis/hemp web page with regulatory changes ...
  • Netherlands Coffee shops ask for delay of experimental phase of cannabis experiment ...
  • South Africa Ban on cannabis edibles sparks legal challenges ...
  • United States FDA issues warning to firm marketing intravenous form of CBD ...
  • Moldova First authorisation for hemp cultivation issued ...
News analysis

FDA needs more data before making CBD rules, Hahn tells US hearing

Written by || 25th March 2020 || News analysis | Health and science | Policy and Politics | Regulation and legislation | GeographiesNorth America United States

FDA commissioner Stephen Hahn has told a Congressional subcommittee that more research and data are needed before the FDA is ready to issue a formal policy on CBD products
Read full article

Download the full news analysis

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.

I'm already a subscriber
Author default picture

CannIntelligence

This article was written by one of CannIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual cannabis and cannabinoid markets. For a full list, please see our Who We Are page.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Thanks for getting in touch with us

Please leave your enquiry and we will get back to you within 24 hours

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.

Sign up to our newsletter

Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.